Evidence map›Paper›PMID 29561432›Full record

ArticleMedicine2018

Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.

Katarzyna Bednarska, Ewa Król, Ewa Głowacka, Hanna Romanowicz, Krzysztof Szyłło, Magdalena Klink, Zofia Sułowska, Marek Nowak

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Katarzyna BednarskaDepartment of Experimental Immunology, Institute of Medical Biology of Polish Academy of Sciences.
Ewa KrólMedical Centre of Laboratory Diagnostics and Screening Tests, Polish Mother's Memorial Hospital Research Institute.
Ewa GłowackaMedical Centre of Laboratory Diagnostics and Screening Tests, Polish Mother's Memorial Hospital Research Institute.
Hanna RomanowiczLaboratory of Cancer Genetics, Department of Pathology.
Krzysztof SzyłłoDepartment of Operative Gynaecology and Gynaecological Oncology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
Magdalena KlinkDepartment of Experimental Immunology, Institute of Medical Biology of Polish Academy of Sciences.
Zofia SułowskaDepartment of Experimental Immunology, Institute of Medical Biology of Polish Academy of Sciences.
Marek NowakDepartment of Operative Gynaecology and Gynaecological Oncology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
Polish Mother’s Memorial Hospital Research Institute · PLPolish Academy of Sciences · PLCancer Genetics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smouldering inflammation, thrombocytosis, and platelet hyper-reactivity are linked to malignancy. The relationships between preoperative diagnostic blood morphology parameters and cancer have been the focus of much interest, because some of these parameters are correlated with advanced cancer stages and poor patient survival rates. This study aimed to perform an observational, retrospective analysis of the intradiversity of blood platelet parameters in patients with different International Federation of Gynaecology and Obstetrics (FIGO) stages and different histological types of epithelial ovarian carcinomas (EOC), and also an analysis of the overall survival rate.In all, 94 EOC patients were included in this analysis (23 mucinous, 33 serous, 20 undifferentiated, 14 endometrioid, and 4 clear cell carcinoma cases). Peripheral blood samples were collected and analyzed before drug or surgical treatment.The platelet-to-neutrophil ratio (PNR) was related to the histological type of EOC, particularly mucinous carcinoma. In patients with mucinous cancer, the PNR was significantly lower compared with patients with nonmucinous cancer, and this parameter distinguished between mucinous and nonmucinous groups of patients (area under receiver-operating characteristic [ROC] curve 0.721 ± .056; sensitivity 82.6%; specificity 61%; P < .001; ROC analysis), regardless of the FIGO stage. Moreover, elevated PNR values were correlated with lower survival rate of EOC patients.The reduced PNR, similar to the lower level of cancer antigen 125, is characteristic for mucinous ovarian carcinoma patients. Moreover, elevated PNR index might correlate with poor survival of patients.

Indexed as

AdultAgedAged, 80 and overAnalysis of VarianceBlood PlateletsCA-125 AntigenCarcinoma, Ovarian EpithelialHumansMembrane ProteinsMiddle AgedNeoplasms, Glandular and EpithelialOvarian NeoplasmsPreoperative PeriodRetrospective StudiesROC CurveSurvival AnalysisCA-125 AntigenMembrane ProteinsMUC16 protein, human

Identifiers

PMID29561432
PMCPMC5895358
OpenAlexW2791988205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.